These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8323986)

  • 1. Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state.
    Adler G; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1993; 242(6):357-61. PubMed ID: 8323986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia, psychoticism, neuroleptics, and auditory evoked potentials.
    Schlör KH; Moises HW; Haas S; Rieger H
    Pharmacopsychiatry; 1985 Sep; 18(5):293-6. PubMed ID: 4048264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients.
    Adler G; Markert U; Gattaz WF
    Pharmacopsychiatry; 1994 Mar; 27(2):68-9. PubMed ID: 7913236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients.
    Hegerl U; Gaebel W; Gutzman H; Ulrich G
    Int J Psychophysiol; 1988 Aug; 6(3):207-14. PubMed ID: 2900230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
    Müller MJ; Wetzel H; Eich FX; Rein W; Puech A; Benkert O;
    J Clin Psychopharmacol; 2002 Dec; 22(6):554-60. PubMed ID: 12454554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspension therapy in acute schizophrenia. Clinical and neuroendocrine/biochemical effects of abrupt discontinuation of neuroleptic medication.
    Kuhs H; Folkerts H
    Neuropsychobiology; 1995; 31(3):135-45. PubMed ID: 7609862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between standard auditory evoked potentials and symptomatology in a group of 50 schizophrenic patients.
    Bougerol T; Benraiss A; Scotto J
    Eur Psychiatry; 1997; 12(8):387-94. PubMed ID: 19698559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of stimulation parameters on auditory stimulus processing in schizophrenia and major depression: an auditory evoked potential study.
    Adler G; Adler J; Schneck M; Armbruster B
    Acta Psychiatr Scand; 1990 May; 81(5):453-8. PubMed ID: 2356768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of rapid neuroleptic response in male patients with schizophrenia.
    Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG
    Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERPs in schizophrenia: effects of antipsychotic medication.
    Ford JM; White PM; Csernansky JG; Faustman WO; Roth WT; Pfefferbaum A
    Biol Psychiatry; 1994 Aug; 36(3):153-70. PubMed ID: 7948453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive evoked potentials in patients with schizophrenia].
    Chen X; Zhang M; Lou F
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):676-8. PubMed ID: 11715457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evoked potentials and the prediction of the efficacy of psychopharmaceutical agents].
    Kolomaznik M; Komzák F; Haloupková L; Seidl I; Hronek J
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):108-10. PubMed ID: 3414239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.
    Graham SJ; Scaife JC; Balboa Verduzco AM; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2004 Jun; 18(2):173-80. PubMed ID: 15260904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory event-related potentials and clinical scores in unmedicated schizophrenic patients.
    Laurent A; Garcia-Larréa L; d'Amato T; Bosson JL; Saoud M; Marie-Cardine M; Maugière F; Dalery J
    Psychiatry Res; 1999 Jun; 86(3):229-38. PubMed ID: 10482342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
    Chengappa KN; Goldstein JM; Greenwood M; John V; Levine J
    Clin Ther; 2003 Feb; 25(2):530-41. PubMed ID: 12749512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preliminary report of evoked potential marker study of pattern shift visual evoked potentials (PS-VEP) and auditory evoked potentials (AEP) on schizophrenic twins].
    Zhang M; Chen X
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):210-3, 252. PubMed ID: 1954791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man.
    Graham SJ; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2001 Dec; 15(4):243-50. PubMed ID: 11769817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.